Dr. Kerstin de Wit, MD
Claim this profileKingston Health Sciences Centre
Studies Cellulitis
Studies Blood Clot
3 reported clinical trials
5 drugs studied
Clinical Trials Kerstin de Wit, MD is currently running
Rivaroxaban vs Apixaban
for Blood Clots
Apixaban and rivaroxaban have been compared to standard therapy for treatment of acute symptomatic venous thromboembolism (VTE) in randomized controlled trials (RCTs), and are both approved by Health Canada. No safety or efficacy data is available from direct head-to-head comparison of these two anticoagulants. Lawsuits in the United States over bleeding events, patient perceptions, and concerns with medication adherence are additional factors highlighting the importance of a comparison trial. This multi-center, pragmatic, prospective, randomized, open-label, blinded end-point (PROBE) trial aims to compare the safety of apixaban and rivaroxaban for the treatment of VTE.
Recruiting3 awards Phase 43 criteria
Reduced-Dose Thrombolytic Therapy
for Pulmonary Embolism
This trial tests a smaller dose of a clot-busting drug combined with a blood thinner in patients with serious lung clots. The goal is to see if this approach is effective and safer than higher doses, reducing the risk of severe bleeding.
Recruiting1 award Phase 37 criteria
More about Kerstin de Wit, MD
Clinical Trial Related1 year of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Kerstin de Wit, MD has experience with
- Cephalexin
- Rivaroxaban
- Apixaban
- Alteplase
- Placebo
Breakdown of trials Kerstin de Wit, MD has run
Cellulitis
Blood Clot
Deep Vein Thrombosis
Pulmonary Embolism
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kerstin de Wit, MD specialize in?
Kerstin de Wit, MD focuses on Cellulitis and Blood Clot. In particular, much of their work with Cellulitis has involved treating patients, or patients who are undergoing treatment.
Is Kerstin de Wit, MD currently recruiting for clinical trials?
Yes, Kerstin de Wit, MD is currently recruiting for 2 clinical trials in Kingston Ontario. If you're interested in participating, you should apply.
Are there any treatments that Kerstin de Wit, MD has studied deeply?
Yes, Kerstin de Wit, MD has studied treatments such as Cephalexin, Rivaroxaban, Apixaban.
What is the best way to schedule an appointment with Kerstin de Wit, MD?
Apply for one of the trials that Kerstin de Wit, MD is conducting.
What is the office address of Kerstin de Wit, MD?
The office of Kerstin de Wit, MD is located at: Kingston Health Sciences Centre, Kingston, Ontario Canada. This is the address for their practice at the Kingston Health Sciences Centre.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.